ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST

Samir Arnaout, Hanady R. Samaha, Julien Succar, Imad Bou-Akl, Khaled M. Musallam, Ali T. Taher
  • Hanady R. Samaha
    American University of Beirut,
  • Julien Succar
    American University of Beirut,
  • Imad Bou-Akl
    American University of Beirut,
  • Khaled M. Musallam
    American University of Beirut,
  • Ali T. Taher
    American University of Beirut,

Abstract

Several factors have been proposed to explain the persistence of a high incidence of venous thromboembolism worldwide with its associated morbidity and mortality. Underutilization of anticoagulants and failure of adherence to thromboprophylaxis guidelines are emerging global health concerns. We herein review this alarming observation with special emphasis on the Middle East region. We also discuss strategies that could help control this increasingly reported problem.

Keywords

thromboembolism; anticoagulation; prophylaxis; underutilization; risk-assessment; developing countries; Middle East

Full Text:

PDF
HTML
Submitted: 2014-06-12 16:03:01
Published: 2011-05-23 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
293

Views:
PDF
124
HTML
687

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Ā 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPressĀ®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185